| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Laboratory for Experimental Medicine and Endocrinology and 2 Division of Biochemistry, University of Leuven, Leuven, Belgium; 3 Laboratory of Tumor and Developmental Biology, University of Liege, Tour de Pathologie (B23), Sart-Tilman, Liege, Belgium; and 4 Institut National de la Santé et de la Recherche Médicale, Centre de Recherches Biomédicales des Cordeliers, Université Paris 6, Paris, France
Requests for reprints: Johannes V. Swinnen, Laboratory for Experimental Medicine and Endocrinology, University of Leuven, Gasthuisberg O&N, Herestraat 49 bus 902, B-3000 Leuven, Belgium. Phone: 32-16-345970; Fax: 32-16-345934; E-mail: johan.swinnen{at}med.kuleuven.ac.be.
Aggressive cancer cells typically show a high rate of energy-consuming anabolic processes driving the synthesis of lipids, proteins, and DNA. Here, we took advantage of the ability of the cell-permeable nucleoside 5-aminoimidazole-4-carboxamide (AICA) riboside to increase the intracellular levels of AICA ribotide, an AMP analogue, mimicking a low energy status of the cell. Treatment of cancer cells with AICA riboside impeded lipogenesis, decreased protein translation, and blocked DNA synthesis. Cells treated with AICA riboside stopped proliferating and lost their invasive properties and their ability to form colonies. When administered in vivo, AICA riboside attenuated the growth of MDA-MB-231 tumors in nude mice. These findings point toward a central tie between energy, anabolism, and cancer and suggest that the cellular energy sensing machinery in cancer cells is an exploitable target for cancer prevention and/or therapy.
Key Words: AICA anabolism AMPK energy cancer
This article has been cited by other articles:
![]() |
K. Choi, E. Mollapour, J. H. Choi, and S. B. Shears Cellular Energetic Status Supervises the Synthesis of Bis-Diphosphoinositol Tetrakisphosphate Independently of AMP-Activated Protein Kinase Mol. Pharmacol., August 1, 2008; 74(2): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beckers, S. Organe, L. Timmermans, F. Vanderhoydonc, L. Deboel, R. Derua, E. Waelkens, K. Brusselmans, G. Verhoeven, and J. V. Swinnen Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside. Mol. Cancer Ther., September 1, 2006; 5(9): 2211 - 2217. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |